BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32100472)

  • 1. Cutaneous findings of familial cerebral cavernous malformation syndrome due to the common Hispanic mutation.
    Manole AK; Forrester VJ; Zlotoff BJ; Hart BL; Morrison LA
    Am J Med Genet A; 2020 May; 182(5):1066-1072. PubMed ID: 32100472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
    Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
    Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased number of white matter lesions in patients with familial cerebral cavernous malformations.
    Golden MJ; Morrison LA; Kim H; Hart BL
    AJNR Am J Neuroradiol; 2015 May; 36(5):899-903. PubMed ID: 25556204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
    Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
    J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial cerebral cavernous malformation: Report of a novel KRIT1 mutation in a Portuguese family.
    Rosário Marques I; Antunes F; Ferreira N; Grunho M
    Seizure; 2017 Dec; 53():72-74. PubMed ID: 29145060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel CCM1/KRIT1 heterozygous deletion mutation (c.1919delT) in a Chinese family with familial cerebral cavernous malformation.
    Yang C; Wu B; Zhong H; Li Y; Zheng X; Xu Y
    Clin Neurol Neurosurg; 2018 Jan; 164():44-46. PubMed ID: 29169046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRIT1 Gene in Patients with Cerebral Cavernous Malformations: Clinical Features and Molecular Characterization of Novel Variants.
    Ricci C; Cerase A; Riolo G; Manasse G; Battistini S
    J Mol Neurosci; 2021 Sep; 71(9):1876-1883. PubMed ID: 33651268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.
    Wang H; Pan Y; Zhang Z; Li X; Xu Z; Suo Y; Li W; Wang Y
    J Mol Neurosci; 2017 Feb; 61(2):221-226. PubMed ID: 28160210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations.
    Sirvente J; Enjolras O; Wassef M; Tournier-Lasserve E; Labauge P
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1066-72. PubMed ID: 19453802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome capture sequencing identifies a novel CCM1 mutation in a Chinese family with multiple cerebral cavernous malformations.
    Mao CY; Yang J; Zhang SY; Luo HY; Song B; Liu YT; Wu J; Sun SL; Yang ZH; Du P; Wang YH; Shi CH; Xu YM
    Int J Neurosci; 2016 Dec; 126(12):1071-6. PubMed ID: 26643368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous venous malformations in familial cerebral cavernomatosis caused by KRIT1 gene mutations.
    Toll A; Parera E; Giménez-Arnau AM; Pou A; Lloreta J; Limaye N; Vikkula M; Pujol RM
    Dermatology; 2009; 218(4):307-13. PubMed ID: 19182478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition.
    Strickland CD; Eberhardt SC; Bartlett MR; Nelson J; Kim H; Morrison LA; Hart BL
    Radiology; 2017 Aug; 284(2):443-450. PubMed ID: 28318403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkeratotic cutaneous vascular malformation associated with familial cerebral cavernous malformations (FCCM) with KRIT1/CCM1 mutation.
    Feldmeyer L; Baumann-Vogel H; Tournier-Lasserve E; Riant F; Jung HH; French LE; Kamarashev J
    Eur J Dermatol; 2014; 24(2):255-7. PubMed ID: 24721395
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?
    Algattas H; Abou-Al-Shaar H; Mendelson M; Arnold GL; Felker J; Meade J; Greene S
    Cancer Genet; 2020 Jun; 244():36-39. PubMed ID: 32434131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.
    Petersen TA; Morrison LA; Schrader RM; Hart BL
    AJNR Am J Neuroradiol; 2010 Feb; 31(2):377-82. PubMed ID: 19833796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.
    Yang C; Nicholas VH; Zhao J; Wu B; Zhong H; Li Y; Xu Y
    J Mol Neurosci; 2017 Apr; 61(4):511-523. PubMed ID: 28255959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel CCM1 (KRIT1) Mutation Detection in Brazilian Familial Cerebral Cavernous Malformation: Different Genetic Variants in Inflammation, Oxidative Stress, and Drug Metabolism Genes Affect Disease Aggressiveness.
    Fontes-Dantas FL; da Fontoura Galvão G; Veloso da Silva E; Alves-Leon S; Cecília da Silva Rêgo C; Garcia DG; Marques SA; Blanco Martinez AM; Reis da Silva M; Marcondes de Souza J
    World Neurosurg; 2020 Jun; 138():535-540.e8. PubMed ID: 32113992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of familial cerebral cavernous malformations and report of seven additional families.
    de Vos IJ; Vreeburg M; Koek GH; van Steensel MA
    Am J Med Genet A; 2017 Feb; 173(2):338-351. PubMed ID: 27792856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.
    Choquet H; Trapani E; Goitre L; Trabalzini L; Akers A; Fontanella M; Hart BL; Morrison LA; Pawlikowska L; Kim H; Retta SF
    Free Radic Biol Med; 2016 Mar; 92():100-109. PubMed ID: 26795600
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.